글로벌 지중해 열병 치료 시장 – 2028년까지의 산업 동향 및 예측

지중해 열병 치료 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 지중해 열병 치료가 2021-2028년 예측 기간 동안 약 5.00%의 CAGR을 보일 것이라고 분석했습니다. 질병 특정 신규 치료법에 대한 수요 증가, 신약 및 치료법 개발을 위한 연구 개발 활동의 급증, 의료 인프라 개발에 대한 지출 증가는 지중해 열병 치료 시장 성장에 기인하는 주요 요인입니다.

가족성 발작성 다발성 장막염으로도 알려진 지중해열 치료는 유전성 자가 염증성 질환입니다. 이 질환에서는 관절, 폐, 복부의 막 내벽에 극심한 통증이 반복적인 발열과 함께 나타납니다.

유전성 질환의 유병률 증가는 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가, 지중해 지역에서 지중해열병의 증가, 규제 당국의 특별 지정 급증도 시장 성장을 촉진하는 다른 요인입니다. 개인의 가처분 소득 증가는 수익성 있는 시장 성장 기회를 창출하는 또 다른 간접적인 결정 요인입니다.

그러나 후진 및 저개발 지역의 질병에 대한 인식 부족은 시장 성장에 큰 도전이 될 것입니다. 또한, 연구 개발 능력과 관련된 높은 비용과 숙련된 전문가의 부족이 시장 성장률을 더욱 떨어뜨릴 것입니다. 엄격한 규제 정책도 시장 성장률을 중단시킬 것입니다.

This Mediterranean fever treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Mediterranean fever treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Mediterranean Fever Treatment Market Scope and Market Size

The Mediterranean fever treatment market is segmented on the basis of type, treatment, drugs, route of administration, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the Mediterranean fever treatment market is segmented into familial Mediterranean fever type 1 and familial Mediterranean fever type 2.
• On the basis of treatment, the Mediterranean fever treatment market is segmented into medication and surgery.
• On the basis of drugs, the Mediterranean fever treatment market is segmented into canakinumab, colchicine and others.
• On the basis of route of administration, the Mediterranean fever treatment market is segmented into oral and injectable.  
• On the basis of end users, the Mediterranean fever treatment market is segmented into hospitals, home care, speciality clinics and others.
• On the basis of distribution channel, the Mediterranean fever treatment market is segmented into hospital pharmacies, retail pharmacies and others.

Mediterranean Fever Treatment Market Country Level Analysis

The Mediterranean fever treatment market is analysed and market size insights and trends are provided by country, type, treatment, drugs, route of administration, end users and distribution channel as referenced above.

The countries covered in the Mediterranean fever treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the Mediterranean fever treatment market owing to the rising expenditure for the development of research and development proficiencies coupled with surge in the cases of Mediterranean fever. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure, growing prevalence of inherited disorders and increasing personal disposable income.

The country section of the Mediterranean fever treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The Mediterranean fever treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Mediterranean Fever Treatment Market Share Analysis

The Mediterranean fever treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Mediterranean fever treatment market.

지중해열 치료제 시장 보고서에 포함된 주요 기업으로는 Alkem Labs, Novartis AG, Amneal Pharmaceuticals LLC, Zydus Cadila, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd, Veru Inc, Regeneron Pharmaceuticals, Inc, Swedish Orphan Biovitrum AB, GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Astrazeneca, Pfizer Inc., Endo Pharmaceuticals Inc, ANI Pharmaceuticals, Inc, Mylan NV, Breckenridge Pharmaceutical, Inc., Abbott 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-47749